|
2024
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes;
pharmaceutical preparations for weigh... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for weight... |
|
|
Invention
|
Insulin containing pharmaceutical compositions.
The present invention is in the field of pharmac... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease,... |
|
|
Invention
|
Semaglutide in medical therapy.
The present invention relates to semaglutide for use in weight m... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes. |
|
|
Invention
|
Stable semaglutide compositions and uses thereof.
The present invention relates to pharmaceutica... |
|
|
Invention
|
Highly potent isvd compounds capable of substituting for fviii(a).
The present invention provide... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
neurodegenerative disorders and diseases. |
|
|
Invention
|
Procoagulant antibodies.
The present invention relates to improved procoagulant antibodies inclu... |
|
|
Invention
|
Fusion compounds and uses thereof.
The invention relates to fusion proteins comprising a GLP-1 p... |
|
|
Invention
|
Automatic injection device with a top release mechanism.
The present invention relates to a hand... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of
cardiovascular diseases, chronic kidney disease... |
|
|
Invention
|
Enhancing neuronal differentiation of neural progenitor cells. The present invention relates to a... |
|
|
Invention
|
Semaglutide in medical therapy. The present invention is directed to use of the GLP-1 receptor ag... |
|
|
Invention
|
Pharmaceutical formulations of an amylin receptor agonist and a glp-1 receptor agonist comprising... |
|
|
Invention
|
Combination therapy for treatment of liver disease.
The present disclosure relates to a method o... |
|
|
Invention
|
Process for the preparation of insulin-zinc complexes.
The invention concerns a process for prep... |
|
|
Invention
|
Shielded needle unit with actuatable release feature. A drug delivery assembly comprising a drug ... |
|
|
Invention
|
Shielded needle unit with rotating needle. A drug delivery assembly comprising a drug-filled cart... |
|
|
Invention
|
Shielded needle unit with actuatable mounting feature. A drug delivery assembly comprising a drug... |
|
|
Invention
|
Shielded needle unit with actuatable container coupling. A needle assembly comprising a needle un... |
|
|
Invention
|
Drug delivery assembly with double-dose prevention. A drug delivery assembly comprises a drug del... |
|
|
Invention
|
Shielded needle unit with axial mounting feature. A drug delivery assembly comprising a drug deli... |
|
|
Invention
|
Long-acting growth hormone receptor antagonist and use thereof. The invention relates to a long-a... |
|
|
Invention
|
Glucose sensitive insulin derivatives. The present invention relates to novel insulin derivatives... |
|
|
Invention
|
Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic... |
|
|
Invention
|
Cells with targeted insertion of a promoter. The invention relates to improved cells for use in c... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of liver
diseases. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of liver diseases.. |
|
|
Invention
|
Fusion compounds and uses thereof. The invention relates to fusion proteins comprising a GLP-1 po... |
|
|
Invention
|
Biological methods. The invention relates to a method of identifying one or more caudal ventral m... |
|
|
Invention
|
Lumen insertable capsule. 1. A drug delivery device (100) comprising: a) a drug chamber (B) confi... |
|
|
Invention
|
Sensor assembly with identifier determination. A system comprising RGB and UV light emitting mean... |
|
|
Invention
|
Co-agonists of the glp-1 and amylin receptors.
The invention relates to a compound comprising a ... |
|
|
Invention
|
Compositions and methods for inhibiting transmembrane serine protease 6 (tmprss6) expression.
Ol... |
|
|
Invention
|
Glp-1 compositions and uses thereof.
The present invention relates to pharmaceutical composition... |
|
|
Invention
|
Glp-1 receptor agonists in dementia.
The present invention relates to improved medical therapies... |
|
2023
|
Invention
|
Therapeutic antibodies.
The present invention concerns human antibodies recognising the human C5... |
|
|
Invention
|
Amylin receptor agonists. The invention relates to a compound comprising an amylin receptor agoni... |
|
|
Invention
|
Cnp compounds. This application relates to new C-type natriuretic peptide (CNP) compounds, pharma... |
|
2022
|
Invention
|
Device for administering a pharmaceutical suspension.
The present invention provides a dose deli... |
|
|
Invention
|
Ingestible device.
An ingestible device may include one or more deployable limbs configured to o... |
|
|
Invention
|
Tablet comprising a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid.
The invention relates to... |
|
|
Invention
|
Sodium n-(8-(2- hydroxybenzoyl)amino)caprylate polymorphic form a.
The present invention relates... |
|
|
Invention
|
Method for providing a cell population enriched in neurons and precursors thereof.
The present i... |
|
|
Invention
|
A single dose injection device.
The invention relates to a pre-filled single dose injection devi... |
|
|
Invention
|
Single stranded rna purification methods.
The present disclosure relates to improved therapeutic... |
|
|
Invention
|
Medical device with fluid acivated actuation mechanism.
A self-righting ingestible capsule compr... |
|
|
Invention
|
Insulin on board for glucose sensitive insulin.
A method of estimating insulin on board (IOB) fo... |
|
|
Invention
|
Drug delivery device for delivering a predefined fixed dose.
A drug delivery device (100, 300) f... |
|
|
Invention
|
Pill |
|
|
Invention
|
Medical device with fluid acivated actuation mechanism.
A capsule device (100), comprising: a) a... |
|
2021
|
Invention
|
Compositions and methods for site-directed mutagenesis.
The present disclosure provides improved... |
|
|
Invention
|
Capsule administering assembly.
A capsule administering assembly (100, 100′) comprising an inges... |
|
2020
|
Invention
|
Pill bottle |
